# Maternal Tdap Immunization in Guatemala

> **NCT02301702** · PHASE2 · COMPLETED · sponsor: **Emory University** · enrollment: 286 (actual)

## Conditions studied

- Pertussis
- Whooping Cough

## Interventions

- **BIOLOGICAL:** Tdap
- **BIOLOGICAL:** Td

## Key facts

- **NCT ID:** NCT02301702
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2019-08-13
- **Final completion:** 2019-08-13
- **Target enrollment:** 286 (ACTUAL)
- **Last updated:** 2019-10-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02301702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02301702, "Maternal Tdap Immunization in Guatemala". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02301702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*